bo medical technologies, the result of the merger of bo pharma and bo esthetics, has subsidiaries in 7 countries in both Benelux as well as Scandinavia. The company is engaged in the exclusive distribution of medical and esthetical devices. We look at cosmetic care from a medical perspective and seek products whose effects are beyond dispute and published in leading medical journals. After years of succesful business in the Benelux, bo medical technologies is now expanding to Scandinavia with breakthrough devices and products for dermatologists and plastic surgeons. The portfolio consists of products for the detection and treatment of skin cancer and products for esthetics.